High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis

American Journal of Hematology

Volumn 76, Issue 4, 2004, Pages 338-342

  Ishikura, Ken ^a   Wada, Hideo ^a   Kamikura, Yuko ^a   Hattori, Kyouko ^a   Fukuzawa, Toshiaki ^a   Yamada, Norikazu ^a   Nakamura, Masio ^a   Nobori, Tsutomu ^a   Nakano, Takeshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti 2GPI antibody; Anti prothrombin antibody; DRVVT; DVT; PE

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOCORTIN 5 ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANNEXINS; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BETA 2-GLYCOPROTEIN I; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTRACRANIAL THROMBOSIS; JAPAN; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; PROTHROMBIN; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 3342977843     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20124     Document Type: Article

References (32)

1. Harris EN. Antiphospholipid syndrome. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby-Year Book: 1994. Section 6, p 32.1-32.6.
2. Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid antibodies. Clin Rheum Dis 1985;11:591-601.
3. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-907.
4. Schulman S, Svenungsson E, Granqvist S, and the Duration of Anticoagulant Study Group. Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 1998;104:332-338.
5. Simioni P, Prandoni P, Zanon E, et al. Deep vein thrombosis and lupus anticoagulant. A case-control study. Thromb Haemost 1996;76:187-189.
6. Ghirardello A, Doria A, Ruffatti A, et al. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome? Ann Rheum Dis 1994;53:140-142.
7. Horbach DA, van Oort E, Donders RC, et al. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus-comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 1996;76:916-924.
8. Nencini P, Baruffi M, Abbate R, Amaducci L, Inzitari D. Lupus anticoagulant and anti-cardiolipin antibodies in young adults with cerebral ischemia. Stroke 1992;23:189-193.
9. Antiphospholipid Antibodies in Stroke Study Group. Clinical, radiological and pathological aspects of cerebrovascular disease associated with antiphospholipid antibodies. Stroke 1993;24 (Suppl 1):S1-123.
10. Vaarala O, Puurunen M, Manttari M, et al. Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995;91:23-27.
11. Fields R, Toubbeh H, Searles R, Bankhurst A. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989;16:623-625.
12. Ginsberg I, Wells P, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995;86:3685-3691.
13. Godfrey T, D'Cruz D. Antiphospholipid syndrome: general features. In: Khamashta MA, editor. Hughes syndrome, antiphospholipid syndrome. Springer: London; 2000. p 8-19.
14. Piette JC, Cacoub P. Antiphospholipid syndrome in the elderly: caution. Circulation 1998;97:2195-2196.
15. Harris EN, Gharavi AE, Patel S, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held April 4, 1986. Clin Exp Immunol 1987;68:215-222.
16. Triplett DA, Brandt JT. Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon. Hematol Pathol 1988;2:121-143.
17. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-178.
18. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983;61:684-692.
19. Van Boven HH, Lane DH. Antithrombin and its inherited deficiency states. Semin Hematol 1997;34:188-204.
20. Bertina RM. Protein C deficiency and venous thrombosis - the search for the second genetic defect. Thromb Haemost 2000;83:360-361.
21. Engesser L, Broekmans AW, Briët E, Brommer EJ, Bertina RM. Hereditary protein S deficiency: clinical manifestation. Ann Intern Med 1987;106:677-682.
22. Sakakura M, Wada H, Watanabe R, et al. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant. Clin Appl Thromb Haemost 2000;6:144-150.
23. Shah NM, Khamashta MA, Atsumi T, Hughes GRV. Outcome of patients with anticardiolipin antibodies: a 10-year follow-up of 52 patients. Lupus 1998;7:3-6.
24. Krnic-Barrie S, Reister O'Connor C, Looney SW, Pierangeli SS, Harris EN. A retrospective review of 61 patients with antiphospholipid syndrome. Arch Intern Med 1997;157:2101-2108
25. 2-glycoprotein 1 - a specific marker for the antiphospholipid syndrome. Clin Exp Immunol 1997;109:304-309.
26. 2- glycoprotein 1 antibodies: detection and association with thrombosis. Br J Haematol 1995;89:397-402.
27. Loeliger A. Prothrombin as a co-factor of the circulating anticoagulant in systemic lupus erythematosus? Thromb Diath Haemorrh 1959;3:237-256.
28. Puurunen M, Vaarala O, Julkunen H, Aho K, Palosuo T. Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1996;80:16-22,
29. Palosuo T, Virtamo J, Haukka J, et al. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men. A nested case-control study, Thromb Haemost 1997;78:1178-1182.
30. Minamikawa N, Wada H, Wakita Y, et al. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism. Thromb Haemost 1994;71:192-194.
31. Yamada N, Wada H, NakaseT, et al. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis. Blood Coagul Fibrinolysis 1995;6:627-633.
32. Nakase T, Wada H, Minamikawa K, et al. Increased activated protein C-protein C inhibitor complex level in patients positive for lupus anticoagulant, Blood Coagul Fibrinolysis 1994;5:173-177.